Stay updated on Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    This change updates the ClinicalTrials.gov page revision version from v3.5.2 to v3.5.3, reflecting a site/software metadata update rather than a change to the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:35:38.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:25:47.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    - Version history updated: Revision v3.5.0 added; Revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-21T00:52:23.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Version bump from v3.4.2 to v3.4.3; study details and user-facing content remain the same.
    Difference
    0.1%
    Check dated 2026-03-06T18:16:21.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added 'Gastric cancer' as a keyword and included the Genetic and Rare Diseases Information Center under Resources. Page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-13T12:35:09.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    A minor page revision tag was added: Revision: v3.4.1, updating from v3.4.0, with no changes to study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T23:40:55.000Z thumbnail image

Stay in the know with updates to Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.